May 25, 2026
ROI
Claims-based women's health savings with a 3.6x ROI
For generations, women's health has been treated as a silent epidemic. Conditions like urinary incontinence, pelvic organ prolapse, chronic pelvic floor dysfunction (a persistent weakness or coordination problem in the muscles of the pelvic floor), and bowel dysfunction have been underresearched, dismissed, and accepted as inevitable consequences of aging or childbirth. Millions of women have been told their symptoms are normal, simply part of life. That acceptance has come at a cost: diminished quality of life, lost productivity, and worsening mental health.
Bloom is Sword Health's AI Care solution for women, built around every life stage, fully remote, and designed to extend access to specialist-led care while delivering measurable reductions in cost.
A dual-validated, claims-based study comparing a matched cohort of 602 participants (Bloom members versus women receiving usual care) shows what better women's care does to a claims book.
3.6:1
3.6:1 Gross ROI in the first 12 months, claims-based analysis vs. matched usual care¹
$3,082
In pelvic-related healthcare savings per member per year¹
What this report helps you analyze
One in 3 women in the U.S. lives with pelvic floor dysfunction (a category that includes urinary incontinence, pelvic organ prolapse, and related conditions), yet the average woman waits 6.5 years before seeking care.² The result is a category of spend that accumulates quietly: lost productivity, escalating interventions, and surgeries that average nearly $30,000 each.³ Most benefits strategies do not address this gap until the cost is already visible on the claims report.
This whitepaper gives employers and health plans the evidence to act before the cost is visible. The Bloom study found an 89% reduction in pelvic surgeries in the Bloom group versus usual care, and a 3.4x reduction in pelvic medical office visits. That reduction drives $3,082 in pelvic-related healthcare savings and $7,688 in total healthcare savings per member per year.¹ The ROI and savings are driven primarily by reductions in those unnecessary surgical and clinical visits.
Access to women's specialist care is limited by geography, scheduling, and a shortage of qualified clinicians. Bloom addresses this by integrating AI Care into a specialist-led model, extending access without compromising clinical quality. Phoenix, Sword's AI Care Specialist, provides real-time support between sessions, giving women's health specialists the context they need to adjust care quickly and deliver better outcomes across a larger population.
Key findings
- A 3.6:1 gross ROI in the first 12 months, from a dual-validated claims-based study of 602 matched participants¹
- $3,082 in pelvic-related healthcare savings and $7,688 in total healthcare savings per member per year, driven primarily by surgery and visit reduction¹
- 89% reduction in pelvic surgeries in the Bloom group versus usual care¹
- 67% of members with menstrual discomfort found meaningful relief after nine sessions⁴
- 57% of members with urinary incontinence found meaningful relief after nine sessions⁴
- 56% reported improvement in workplace productivity⁵
- 51% recovered to non-clinical levels of anxiety; 47% recovered to non-clinical levels of depression⁶
Acknowledgments
This report reflects the expertise and dedication of Bloom's clinical team — the women's health specialists, clinical researchers, and outcomes analysts whose contributions made this analysis possible.
Contributors to White Paper

Senior Director of Clinical Research, Sword Health

Vice President, Health Economics

Head of Clinical Affairs, Sword Bloom
Footnotes
- 1
Claims-based dual-validation study. Matched cohort of 602 participants (Bloom members versus women receiving usual care). J Med Econ. 2026;29(1):516-531.
- 2
Sci Rep 12, 9878 (2022). https://doi.org/10.1038/s41598-022-13501-w
- 3
PLoS One. 2023 Feb 9;18(2):e0269828. doi: 10.1371/journal.pone.0269828. PMID: 36757947; PMCID: PMC9910684.
- 4
Sword member data, 2024. Relief defined as scoring 5/7 or higher on the PGIC scale after 9 sessions.
- 5
Sword member data, 2024. Clinically significant improvement in overall productivity levels (MID >7 pts).
- 6
Sword member data, 2024. Members scoring 10 or above on GAD-7 or PHQ-9 who ended the program no longer reporting clinically significant symptoms.